insights

Modernizing CTAs: Our Series Featured in Clinical Leader

06-25-25 Alert Katherine Leibowitz

We’re pleased to share that Clinical Leader recently published a two-part series by Katherine Leibowitz and Catherine London on how to update clinical trial agreements (CTAs) for today’s digital and data-driven landscape.

Read the articles on Clinical Leader:

Part One: “Refresh Your CTA Strategy with Cybersecurity and EHRs In Mind, Part One”
Part Two: “How AI And Secondary Data Use Are Changing the Way We Do CTAs, Part Two”

The series explores pressing issues in CTA negotiation, including:

Integrating cybersecurity and data privacy safeguards
Ensuring appropriate EHR system controls and certifications
Addressing secondary research and secondary use of study data
Tailoring study data licenses to balance academic and sponsor interests
Managing AI risks, rights, and downstream data access
Clarifying data use and confidentially obligations in the AI era

Many thanks to Clinical Leader for featuring our work.

SHARE: LINKEDIN TWITTER

This contents of this alert should not be construed as legal advice or a legal opinion on any specific facts or circumstances. This content is not intended to and does not, by its receipt, create an attorney-client relationship. The contents are intended for general informational purposes only. We urge you to consult your attorney about the specific situation and any legal questions you may have. Attorney advertising in some jurisdictions. © 2025 Leibowitz Law. All rights reserved. “Leibowitz Law” is a trade name of Leibowitz LLC.

Want to receive notifications?

To be notified when we post new Insights, please sign up for our email list. As industry thought leaders, Leibowitz Law Insights address developing issues at the intersection of law, regulation, technology and life sciences…